RecruitingNCT07360418

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

A Prospective Multicenter Study Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial


Sponsor

Applied Biologics, LLC

Enrollment

50 participants

Start Date

Oct 16, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • The potential subject must have participated in the CAMPX trial and achieved complete closure by the 12-week endpoint.

Exclusion Criteria2

  • The potential subject did not participate in the CAMPX trial.
  • The potential subject participated in the CAMPX trial and did not achieve complete closure.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlue Drop Foot Scanner

Subjects with eligible wound will receive a BlueDrop® OneStep Foot Scanner™. They are instructed to step on the scale each morning. The Bluetooth technology transmits a photograph and thermal image to the central monitoring nurse at BlueDrop®. All information transmitted is compliant with HIPPA regulations. Subjects that are unable to use the scale will receive a phone call at months 3,6, 9 and 12 months to determine if the foot has remained closed.


Locations(1)

Detroit Foot and Ankle

Clinton Township, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07360418


Related Trials